申请人:BOEHRINGER INGELHEIM INT
公开号:WO2015022332A1
公开(公告)日:2015-02-19
The present invention encompasses compounds of general formula (I) wherein the groups R1 to R3 and X1 through X6 have the meanings given in the claims and in the specification. The compounds of the invention are suitable for the treatment of diseases characterized by excessive or abnormal cell proliferation pharmaceutical preparations containing such compounds and their uses as a medicament.
本发明涵盖了一般式(I)中的化合物,其中基团R1到R3和X1到X6的含义如权利要求和说明书中所述。本发明的化合物适用于治疗以细胞过度或异常增殖为特征的疾病,包括含有这些化合物的药物制剂及其用作药物的用途。